Transdermal Drug Patches to 2028


wearable subcutaneous infusion systems  Transdermal Drug Patches to 2028  JDP808K December 2020 • US$3,850 


 

 

Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2028.

 

transdermal drug patches

 

 

 

Transdermal Drug Patches to 2028 – What You Will Learn

• Analyzes and evaluates current transdermal drug patch markets and products and assesses the market potential for existing and probable future products
• Analyzes patch designs, technologies and patch development issues
• Profiles patch manufacturers and third-party transdermal supply chain companies
• Provides detailed assessments of more than forty patch products in more than a dozen product categories
• Provides market data and forecasts to 2028
• Profiles transdermal drug patch product providers, their product development activity, and strategies
• Evaluates the impact of economic, technology, and regulatory factors

 

Summary of Contents

Executive Summary

The Market Opportunity
Transdermal Drug Delivery Dynamics
Demand Drivers
Competitive Landscape
Factors Limiting Growth
Pharmacokinetics & Dosage Forms
Patch Manufacturing Dynamics
Patch Manufacturing Company Profiles

Product Analysis –
FDA-Approved Drugs Delivered via Transdermal Patches

Alkaloids
Androgens
Antidepressants
Antiemetics
Antispasmodics
CNS Stimulants
Cholinesterase Inhibitors
Dopamine Agonists
Hormone Replacement
Hypotensive Agents
Local Anesthetics
NSAIDs
Opioid Analgesics
Progestrins
Trinitrates

Development-stage Drug Patches

Market Analysis – Transdermal Drug Patch Therapeutics
ADHD
Addiction
Contraception
Cardiovascular/Angina
Depression
Hormone Replacement Therapy
Hypertension
Motion Sickness
Neurology
Osteoporosis
Pain Management

Market Factors
Regulatory Issues
IP and Expiring Patents
Rx-to-OTC Switching
Patient Compliance and Ease of Use
Healthcare Economics

Company Profiles